Drug Profile
Breflate
Alternative Names: NSC 656202Latest Information Update: 01 May 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Southern Research Institute
- Class Antineoplastics
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer